Treatment of Parkinson's disease with NADH-Reference-Cited by-同舟云学术

Treatment of Parkinson's disease with NADH

Published:2009-01-29 Issue:5 Volume:90 Page:345-347
ISSN:0001-6314
Container-title:Acta Neurologica Scandinavica
language:en
Short-container-title:

Author:

Dizdar N.,Kågedal B.,Lindvall B.

Publisher

Wiley

Subject

Clinical Neurology,Neurology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-0404.1994.tb02735.x/fullpdf

Reference10 articles.

1. Verteilung von Noradrenalin und Dopamin (4 hydroxytyramin) im Gehirn des Menchen und ihr verhalten bei Erkrankungen des extrapy-ramidalen Systems;Ehringer;Klin Wschr,1960

2. Distribution of tyrosine hydroxylase in human and animal brain;McGeer;J Neurochem,1971

3. Solubilization and partial purification of tyrosine hydroxylase from bovine adrenal medulla;Shiman;J Biol Chem,1971

4. Biopterine in human brain and urine from controls and parkinsonian patients: application of a new radioimmunoassay;Nagatsu;Clin Chim Acta,1981

5. Nagatsu T Tamaguchi T Rahman K et al. Catecholamine related enzymes and biopterin cofactor in Parkinson's disease Abstr VII Int. Symp Parkinson's Disease 1982 82

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Beyond Pellagra—Research Models and Strategies Addressing the Enduring Clinical Relevance of NAD Deficiency in Aging and Disease;Cells;2023-02-03

2. Clinical Evidence for Targeting NAD Therapeutically;Pharmaceuticals;2020-09-15

3. NAD+ in Brain Aging and Neurodegenerative Disorders;Cell Metabolism;2019-10

4. PGC-1α, Sirtuins and PARPs in Huntington’s Disease and Other Neurodegenerative Conditions: NAD+ to Rule Them All;Neurochemical Research;2019-05-07

5. Mitochondrial Dysfunction and Chronic Disease: Treatment with Membrane Lipid Replacement and Other Natural Supplements;Mitochondrial Biology and Experimental Therapeutics;2018